J&J acquires experimental skin disorder drug for $1.25 billion

NUMAB THERAPEUTICS-JOHNSON&JOHNSON/M&A (UPDATE 2, PIX)UPDATE 2-J&J acquires experimental skin disorder drug for $1.25 billion
Read The Rest at :